FTC goes after GoodRx, the controversy around lifesaving devices, and Verily’s future research
You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday.
The controversy around vena cava filters
